NCT02227017View on ClinicalTrials.gov

Relative Bioavailability of Tipranavir (TPV)/Ritonavir (RTV) at Steady State Administered as Oral Solutions vs. Capsules in the Fed and Fasted State in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

April 30, 2006

Conditions
Healthy
Interventions
DRUG

TPV capsule

DRUG

TPV solution

DRUG

RTV capsule

DRUG

RTV solution

OTHER

standard meal

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY